Baidu
map

常断供的廉价化疗药,你知道我在等你吗?

2016-12-17 宋芳华 医学界肿瘤频道

肿瘤科医生和患者们,你们可曾遇到过这种情况:医生:化疗方案里需要用到×××,但是现在没有药……患者和家属:医生说我们需要用×××,但是现在医院没有药,医院还说没有药商供药,我们跑遍了本地的各大医院,也没有买到……这可怎么办啊,真是急死人了!或者,你又是否在网上看过这样的求助帖子:谁有卖长春花碱的联系方式,谢谢!不知你有没有想过,如果这些化疗药物消失,我们会面临什么局面?肿瘤科有一些廉价或者用量不是

肿瘤科医生和患者们,你们可曾遇到过这种情况:

医生:化疗方案里需要用到×××,但是现在没有药……

患者和家属:医生说我们需要用×××,但是现在医院没有药,医院还说没有药商供药,我们跑遍了本地的各大医院,也没有买到……这可怎么办啊,真是急死人了!

或者,你又是否在网上看过这样的求助帖子:

谁有卖长春花碱的联系方式,谢谢!

不知你有没有想过,如果这些化疗药物消失,我们会面临什么局面?

肿瘤科有一些廉价或者用量不是很大的药物,经常在临床看不到它们的身影,作为一个肿瘤科大夫,深恐它们哪一天会消失。

因为在很多治疗方案里,它们是不可缺少的,甚至不能被其它药物所替代。巧妇难为无米之炊,对于医生来说,它们就是这个米。

而这些遭遇过断供的“米”有:

1、长春新碱:

主要用于恶性淋巴瘤、急性白血病(尤其是儿童白血病)的治疗,还可以用于慢性白血病、生殖细胞肿瘤及小细胞肺癌等肿瘤的治疗。

1 mg/支包装医院售价为23.8元(不同生产厂家及不同地区价格有浮动),在某些医院会出现断供。淋巴瘤及白血病均属化疗可能治愈性疾病。

2、长春花碱:


主要用于霍奇金淋巴瘤、绒毛膜上皮癌的治疗,疗效较好。对于白血病、恶性黑色素瘤等肿瘤也有一定疗效。

霍奇金淋巴瘤与绒癌也属化疗可能治愈性疾病。(请原谅我,医院无药,不知确切价钱,反正是廉价药)。

3、环磷酰胺:

环磷酰胺为某些乳腺癌患者的一线化疗方案中的重要药物,也是治疗淋巴瘤、白血病、卵巢癌等的重要药物。环磷酰胺也是重要的免疫抑制剂,可用于类风湿关节炎及儿童肾病综合征、自身免疫性疾病的治疗。

0.2g/支包装医院售价为5.69元(不同生产厂家及不同地区价格有浮动),在不久的以前,我曾经遇到过环磷酰胺的断供。

4、博来霉素:

博来霉素常用于淋巴瘤、头颈部肿瘤、子宫颈癌、阴茎癌等肿瘤的治疗。由于该药使用量较小,价格也不贵等原因,此药可谓稀缺。

5、更生霉素(放线菌素D):


主要用于滋养细胞肿瘤,而滋养细胞肿瘤主要治疗就是化疗。更生霉素需求量不大,价格更是低廉,一支不足20元。

还有一些价格低廉或者用量较小的化疗药物,也有断供的风险,比如:

5-氟尿嘧啶,该药是广谱抗肿瘤药物,使用范围广泛,但此药一度降至10元以下,不知道此药会不会有断供风险。

甲氨蝶呤,无论针剂还是片剂,价格都非常低廉,甲氨蝶呤是治疗白血病的常用药物,也是治疗绒癌的药物之一,也用于治疗自身免疫性疾病

也许有人会说,这些国产药物消失了,还会有进口的吧!当然,国外有些药物价格高于同类国产药物,但是用量较少的药物,他们就一定会生产吗?

在降低药品价格的大趋势下,国家已对很多廉价药物开放定价,不知道这会不会改变那些廉价且使用量较小的药物的命运。但是,我们期待,患者能够及时地用上他们需要使用的药物。

我们不想面临找不到需要所用药物的情况。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=166433, encodeId=55eb166433ae, content=都是社会通的, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161012/IMG57FE37B9D8B7C2781.jpg, createdBy=05f31956923, createdName=1e128d2fm65(暂无匿称), createdTime=Wed Dec 28 23:14:18 CST 2016, time=2016-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165234, encodeId=1e8a16523472, content=是的,经常给同学讲, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170206/IMG589879E392F941842.jpg, createdBy=f4d469996, createdName=wangyunyb, createdTime=Sat Dec 24 06:01:58 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164090, encodeId=60051640905d, content=哎呀!看到这个题目让我吃惊,看够等于没看, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Mon Dec 19 14:12:13 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581743, encodeId=d29b1581e43a1, content=<a href='/topic/show?id=0813335e996' target=_blank style='color:#2F92EE;'>#化疗药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33579, encryptionId=0813335e996, topicName=化疗药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=298f16872689, createdName=12498cb5m18暂无昵称, createdTime=Mon Dec 19 11:41:00 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163732, encodeId=7ea3163e3222, content=我们期待,患者能够及时地用上他们需要使用的药物。不想面临找不到需要所用药物的情况。, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sun Dec 18 09:51:29 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163723, encodeId=e2dc163e2319, content=全是肿瘤方面的, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1dcc1664035, createdName=idream999999, createdTime=Sun Dec 18 09:45:10 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163664, encodeId=7aea1636641b, content=学习了 之前并不了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e9c1996425, createdName=SAd, createdTime=Sun Dec 18 06:11:18 CST 2016, time=2016-12-18, status=1, ipAttribution=)]
    2016-12-28 1e128d2fm65(暂无匿称)

    都是社会通的

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=166433, encodeId=55eb166433ae, content=都是社会通的, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161012/IMG57FE37B9D8B7C2781.jpg, createdBy=05f31956923, createdName=1e128d2fm65(暂无匿称), createdTime=Wed Dec 28 23:14:18 CST 2016, time=2016-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165234, encodeId=1e8a16523472, content=是的,经常给同学讲, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170206/IMG589879E392F941842.jpg, createdBy=f4d469996, createdName=wangyunyb, createdTime=Sat Dec 24 06:01:58 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164090, encodeId=60051640905d, content=哎呀!看到这个题目让我吃惊,看够等于没看, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Mon Dec 19 14:12:13 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581743, encodeId=d29b1581e43a1, content=<a href='/topic/show?id=0813335e996' target=_blank style='color:#2F92EE;'>#化疗药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33579, encryptionId=0813335e996, topicName=化疗药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=298f16872689, createdName=12498cb5m18暂无昵称, createdTime=Mon Dec 19 11:41:00 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163732, encodeId=7ea3163e3222, content=我们期待,患者能够及时地用上他们需要使用的药物。不想面临找不到需要所用药物的情况。, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sun Dec 18 09:51:29 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163723, encodeId=e2dc163e2319, content=全是肿瘤方面的, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1dcc1664035, createdName=idream999999, createdTime=Sun Dec 18 09:45:10 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163664, encodeId=7aea1636641b, content=学习了 之前并不了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e9c1996425, createdName=SAd, createdTime=Sun Dec 18 06:11:18 CST 2016, time=2016-12-18, status=1, ipAttribution=)]
    2016-12-24 wangyunyb

    是的,经常给同学讲

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=166433, encodeId=55eb166433ae, content=都是社会通的, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161012/IMG57FE37B9D8B7C2781.jpg, createdBy=05f31956923, createdName=1e128d2fm65(暂无匿称), createdTime=Wed Dec 28 23:14:18 CST 2016, time=2016-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165234, encodeId=1e8a16523472, content=是的,经常给同学讲, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170206/IMG589879E392F941842.jpg, createdBy=f4d469996, createdName=wangyunyb, createdTime=Sat Dec 24 06:01:58 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164090, encodeId=60051640905d, content=哎呀!看到这个题目让我吃惊,看够等于没看, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Mon Dec 19 14:12:13 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581743, encodeId=d29b1581e43a1, content=<a href='/topic/show?id=0813335e996' target=_blank style='color:#2F92EE;'>#化疗药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33579, encryptionId=0813335e996, topicName=化疗药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=298f16872689, createdName=12498cb5m18暂无昵称, createdTime=Mon Dec 19 11:41:00 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163732, encodeId=7ea3163e3222, content=我们期待,患者能够及时地用上他们需要使用的药物。不想面临找不到需要所用药物的情况。, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sun Dec 18 09:51:29 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163723, encodeId=e2dc163e2319, content=全是肿瘤方面的, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1dcc1664035, createdName=idream999999, createdTime=Sun Dec 18 09:45:10 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163664, encodeId=7aea1636641b, content=学习了 之前并不了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e9c1996425, createdName=SAd, createdTime=Sun Dec 18 06:11:18 CST 2016, time=2016-12-18, status=1, ipAttribution=)]
    2016-12-19 cqykthl

    哎呀!看到这个题目让我吃惊,看够等于没看

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=166433, encodeId=55eb166433ae, content=都是社会通的, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161012/IMG57FE37B9D8B7C2781.jpg, createdBy=05f31956923, createdName=1e128d2fm65(暂无匿称), createdTime=Wed Dec 28 23:14:18 CST 2016, time=2016-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165234, encodeId=1e8a16523472, content=是的,经常给同学讲, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170206/IMG589879E392F941842.jpg, createdBy=f4d469996, createdName=wangyunyb, createdTime=Sat Dec 24 06:01:58 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164090, encodeId=60051640905d, content=哎呀!看到这个题目让我吃惊,看够等于没看, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Mon Dec 19 14:12:13 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581743, encodeId=d29b1581e43a1, content=<a href='/topic/show?id=0813335e996' target=_blank style='color:#2F92EE;'>#化疗药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33579, encryptionId=0813335e996, topicName=化疗药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=298f16872689, createdName=12498cb5m18暂无昵称, createdTime=Mon Dec 19 11:41:00 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163732, encodeId=7ea3163e3222, content=我们期待,患者能够及时地用上他们需要使用的药物。不想面临找不到需要所用药物的情况。, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sun Dec 18 09:51:29 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163723, encodeId=e2dc163e2319, content=全是肿瘤方面的, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1dcc1664035, createdName=idream999999, createdTime=Sun Dec 18 09:45:10 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163664, encodeId=7aea1636641b, content=学习了 之前并不了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e9c1996425, createdName=SAd, createdTime=Sun Dec 18 06:11:18 CST 2016, time=2016-12-18, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=166433, encodeId=55eb166433ae, content=都是社会通的, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161012/IMG57FE37B9D8B7C2781.jpg, createdBy=05f31956923, createdName=1e128d2fm65(暂无匿称), createdTime=Wed Dec 28 23:14:18 CST 2016, time=2016-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165234, encodeId=1e8a16523472, content=是的,经常给同学讲, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170206/IMG589879E392F941842.jpg, createdBy=f4d469996, createdName=wangyunyb, createdTime=Sat Dec 24 06:01:58 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164090, encodeId=60051640905d, content=哎呀!看到这个题目让我吃惊,看够等于没看, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Mon Dec 19 14:12:13 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581743, encodeId=d29b1581e43a1, content=<a href='/topic/show?id=0813335e996' target=_blank style='color:#2F92EE;'>#化疗药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33579, encryptionId=0813335e996, topicName=化疗药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=298f16872689, createdName=12498cb5m18暂无昵称, createdTime=Mon Dec 19 11:41:00 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163732, encodeId=7ea3163e3222, content=我们期待,患者能够及时地用上他们需要使用的药物。不想面临找不到需要所用药物的情况。, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sun Dec 18 09:51:29 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163723, encodeId=e2dc163e2319, content=全是肿瘤方面的, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1dcc1664035, createdName=idream999999, createdTime=Sun Dec 18 09:45:10 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163664, encodeId=7aea1636641b, content=学习了 之前并不了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e9c1996425, createdName=SAd, createdTime=Sun Dec 18 06:11:18 CST 2016, time=2016-12-18, status=1, ipAttribution=)]
    2016-12-18 ylzr123

    我们期待,患者能够及时地用上他们需要使用的药物。不想面临找不到需要所用药物的情况。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=166433, encodeId=55eb166433ae, content=都是社会通的, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161012/IMG57FE37B9D8B7C2781.jpg, createdBy=05f31956923, createdName=1e128d2fm65(暂无匿称), createdTime=Wed Dec 28 23:14:18 CST 2016, time=2016-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165234, encodeId=1e8a16523472, content=是的,经常给同学讲, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170206/IMG589879E392F941842.jpg, createdBy=f4d469996, createdName=wangyunyb, createdTime=Sat Dec 24 06:01:58 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164090, encodeId=60051640905d, content=哎呀!看到这个题目让我吃惊,看够等于没看, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Mon Dec 19 14:12:13 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581743, encodeId=d29b1581e43a1, content=<a href='/topic/show?id=0813335e996' target=_blank style='color:#2F92EE;'>#化疗药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33579, encryptionId=0813335e996, topicName=化疗药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=298f16872689, createdName=12498cb5m18暂无昵称, createdTime=Mon Dec 19 11:41:00 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163732, encodeId=7ea3163e3222, content=我们期待,患者能够及时地用上他们需要使用的药物。不想面临找不到需要所用药物的情况。, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sun Dec 18 09:51:29 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163723, encodeId=e2dc163e2319, content=全是肿瘤方面的, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1dcc1664035, createdName=idream999999, createdTime=Sun Dec 18 09:45:10 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163664, encodeId=7aea1636641b, content=学习了 之前并不了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e9c1996425, createdName=SAd, createdTime=Sun Dec 18 06:11:18 CST 2016, time=2016-12-18, status=1, ipAttribution=)]
    2016-12-18 idream999999

    全是肿瘤方面的

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=166433, encodeId=55eb166433ae, content=都是社会通的, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161012/IMG57FE37B9D8B7C2781.jpg, createdBy=05f31956923, createdName=1e128d2fm65(暂无匿称), createdTime=Wed Dec 28 23:14:18 CST 2016, time=2016-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165234, encodeId=1e8a16523472, content=是的,经常给同学讲, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170206/IMG589879E392F941842.jpg, createdBy=f4d469996, createdName=wangyunyb, createdTime=Sat Dec 24 06:01:58 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164090, encodeId=60051640905d, content=哎呀!看到这个题目让我吃惊,看够等于没看, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Mon Dec 19 14:12:13 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581743, encodeId=d29b1581e43a1, content=<a href='/topic/show?id=0813335e996' target=_blank style='color:#2F92EE;'>#化疗药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33579, encryptionId=0813335e996, topicName=化疗药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=298f16872689, createdName=12498cb5m18暂无昵称, createdTime=Mon Dec 19 11:41:00 CST 2016, time=2016-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163732, encodeId=7ea3163e3222, content=我们期待,患者能够及时地用上他们需要使用的药物。不想面临找不到需要所用药物的情况。, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7s7ZCKOmmbBTD6nE7gcd5OZpvyGEzkxBP3S275k5ZJVrsPkotZhBglRHM9rKvcj1OgkssqhcnoPw8zIaMZTF8c/0, createdBy=4c441942088, createdName=ylzr123, createdTime=Sun Dec 18 09:51:29 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163723, encodeId=e2dc163e2319, content=全是肿瘤方面的, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1dcc1664035, createdName=idream999999, createdTime=Sun Dec 18 09:45:10 CST 2016, time=2016-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=163664, encodeId=7aea1636641b, content=学习了 之前并不了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e9c1996425, createdName=SAd, createdTime=Sun Dec 18 06:11:18 CST 2016, time=2016-12-18, status=1, ipAttribution=)]
    2016-12-18 SAd

    学习了 之前并不了解

    0

相关资讯

化疗药的前世今生

说化疗加速死亡,倒也不算是空穴来风,用“三人成虎”来形容更确切。因为,这种谣言从很早以前就开始了。 化疗药的前世今生 现代化疗药物鼻祖的,是氮芥,它有个俗称叫“芥子气”。熟悉战争的朋友一定会联想起很多骇人听闻的故事吧。 没错,它一开始并没有用作药物,而是一战中的致命化学武器。当时,美国病理学家研究受芥子气毒害的士兵,发现他们的骨髓几乎失去了造血功能。直到1942 年,美国胸科大夫古斯塔夫根据

新型化疗药物保育抗癌双管齐下

近日,美国西北大学费恩博格医学院科学家们开发出了一种新型纳米化疗药物,这种药物不仅能降低对女性生育能力的毒副作用,同时还能增强对肿瘤的攻击效果。该药物是第一种通过体外试验来检测其对女性生育能力的药物。  联合研究员、该医学院生育保护系主任Teresa Woodruff表示:“我们的最终目标是研发出一种既能抗癌又能保护女性生育能力的智能药物。”相关的研究成果于20日被发表在《公共图书馆期刊》上。  

Plos One: 新型纳米化疗药物保育抗癌双管齐下

  近日,美国西北大学费恩博格医学院科学家们开发出了一种新型纳米化疗药物,这种药物不仅能降低对女性生育能力的毒副作用,同时还能增强对肿瘤的攻击效果。该药物是第一种通过体外试验来检测其对女性生育能力的药物。   联合研究员、该医学院生育保护系主任Teresa Woodruff表示:“我们的最终目标是研发出一种既能抗癌又能保护女性生育能力的智能药物。”相关的研究成果于20日被发表在Plos One上

Baidu
map
Baidu
map
Baidu
map